SCHEMBL28848014

SCHEMBL28848014

CCCCCC1(CCC(C)C)CCCCC1=O

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.35
CETP P11597 3/20 0.33
CDC25A P30304 1/20 0.31
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8622131 0.89 SIRT2 (0.41) SIRT2CETPLMNA
SCHEMBL8624874 0.87 SIRT2 (0.43) SIRT2CETP
SCHEMBL28209529 0.86 SIRT2 (0.35) SIRT2CETP
SCHEMBL5697005 0.85 SIRT2 (0.39) SIRT2CETPLMNA
SCHEMBL8622095 0.84 SIRT2 (0.45) SIRT2
SCHEMBL8622049 0.84 SIRT2 (0.35) SIRT2CETPLMNA
SCHEMBL8621156 0.82 SIRT2 (0.47) SIRT2
SCHEMBL8622062 0.78 SIRT2 (0.39) SIRT2
SCHEMBL6683846 0.78 SIRT2 (0.39) SIRT2CETP
SCHEMBL6909148 0.78 SIRT2 (0.49) SIRT2CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107072214-A Mineral-based composition and use thereof 安约恩生物制品公司 2017-08-18 CN disclosed
CN-107007546-A For the oxymetazoline drug cream composition for the symptom for treating rosacea 阿勒根公司 2017-08-04 CN disclosed